Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1990 Apr;80(4):471–473. doi: 10.2105/ajph.80.4.471

Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction.

M A Barry 1, D Gleavy 1, K Herd 1, P J Schwingl 1, B G Werner 1
PMCID: PMC1404596  PMID: 2316772

Abstract

Following an outbreak of hepatitis B (HBV) in a municipal house of correction, HBV markers were detected in 173/406 (43 percent) inmates and 10/129 (8 percent) staff. Of the 173 HBV-infected inmates, 14 (8 percent) had hepatitis D (HDV) markers compared to 0/10 staff members. Intravenous drugs use (IVDU) was most strongly associated with HBV marker presence. Increasing duration of imprisonment, history of hepatitis B and especially IVDU were associated with the prevalence of HDV markers.

Full text

PDF
471

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anda R. F., Perlman S. B., D'Alessio D. J., Davis J. P., Dodson V. N. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health. 1985 Oct;75(10):1182–1185. doi: 10.2105/ajph.75.10.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Caredda F., Rossi E., d'Arminio Monforte A., Zampini L., Re T., Meroni B., Moroni M. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis. 1985 May;151(5):925–928. doi: 10.1093/infdis/151.5.925. [DOI] [PubMed] [Google Scholar]
  3. Chiaramonte M., Trivello R., Renzulli G., Zampieri L., Fanecco A., Floreani A., Naccarato R. Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond) 1982 Aug;89(1):53–58. doi: 10.1017/s0022172400070534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Decker M. D., Vaughn W. K., Brodie J. S., Hutcheson R. H., Jr, Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984 Sep;150(3):450–459. doi: 10.1093/infdis/150.3.450. [DOI] [PubMed] [Google Scholar]
  5. Hull H. F., Lyons L. H., Mann J. M., Hadler S. C., Steece R., Skeels M. R. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985 Oct;75(10):1213–1214. doi: 10.2105/ajph.75.10.1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jacobson I. M., Dienstag J. L., Werner B. G., Brettler D. B., Levine P. H., Mushahwar I. K. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985 Mar-Apr;5(2):188–191. doi: 10.1002/hep.1840050205. [DOI] [PubMed] [Google Scholar]
  7. Kaufman M. L., Faiver K. L., Harness J. K. Hepatitis B markers among Michigan prisoners. Ann Intern Med. 1983 Apr;98(4):558–558. doi: 10.7326/0003-4819-98-4-558_1. [DOI] [PubMed] [Google Scholar]
  8. Koplan J. P., Walker J. A., Bryan J. A., Berquist K. R. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis. 1978 Apr;137(4):505–506. doi: 10.1093/infdis/137.4.505. [DOI] [PubMed] [Google Scholar]
  9. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  10. Ponzetto A., Seeff L. B., Buskell-Bales Z., Ishak K. G., Hoofnagle J. H., Zimmerman H. J., Purcell R. H., Gerin J. L. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology. 1984 Nov-Dec;4(6):1111–1115. doi: 10.1002/hep.1840040603. [DOI] [PubMed] [Google Scholar]
  11. Rizzetto M. The delta agent. Hepatology. 1983 Sep-Oct;3(5):729–737. doi: 10.1002/hep.1840030518. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES